BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/110/0.1/20.09.24 | Real-time Boerse Frankfurt Warrants 15:52:40 26/06/2024 BST | ||
| 0.063 EUR | +6.78% |
|
| Current month | +18.00% | ||
| 1 month | -1.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 0.063 | +6.78% |
| 25/06/24 | 0.059 | -11.94% |
| 24/06/24 | 0.067 | -8.22% |
| 21/06/24 | 0.073 | +1.39% |
| 20/06/24 | 0.072 | +28.57% |
Real-time Boerse Frankfurt Warrants
Last update June 26, 2024 at 03:52 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD1Z1D |
| ISIN | DE000VD1Z1D6 |
| Date issued | 11/03/2024 |
| Strike | 110 $ |
| Maturity | 20/09/2024 (86 Days) |
| Parity | 10 : 1 |
| Emission price | 0.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.38 € |
|---|---|
| Lowest since issue | 0.036 € |
| Spread | 0.01 € |
| Spread % | 12.82% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.05
USD
Spread / Average Target
+5.46%
- Stock Market
- Warrants
- Warrant
